Works by Imafuku, Shinichi


Results: 152
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study.

    Published in:
    Dermatology & Therapy, 2024, v. 14, n. 7, p. 1863, doi. 10.1007/s13555-024-01195-z
    By:
    • Okubo, Yukari;
    • Terui, Tadashi;
    • Kobayashi, Satomi;
    • Sano, Shigetoshi;
    • Morita, Akimichi;
    • Imafuku, Shinichi;
    • Tada, Yayoi;
    • Abe, Masatoshi;
    • Yaguchi, Masafumi;
    • Kimura, Takeshi;
    • Shimauchi, Junichiro;
    • Zhang, Wendy;
    • Amouzadeh, Hamid;
    • Murakami, Masamoto
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population.

    Published in:
    International Journal of Clinical Oncology, 2017, v. 22, n. 3, p. 577, doi. 10.1007/s10147-017-1095-0
    By:
    • Shibayama, Yoshitsugu;
    • Namikawa, Kenjiro;
    • Sone, Miyuki;
    • Takahashi, Akira;
    • Tsutsumida, Arata;
    • Sugawara, Shunsuke;
    • Arai, Yasuaki;
    • Aihara, Yukiko;
    • Suzuki, Shigenobu;
    • Nakayama, Juichiro;
    • Imafuku, Shinichi;
    • Yamazaki, Naoya
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open‐label, phase 3 trial.

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2024, v. 51, n. 3, p. 365, doi. 10.1111/1346-8138.17074
    By:
    • Imafuku, Shinichi;
    • Okubo, Yukari;
    • Tada, Yayoi;
    • Ohtsuki, Mamitaro;
    • Colston, Elizabeth;
    • Napoli, Andrew;
    • Shao, Yanqiu;
    • Banerjee, Subhashis;
    • Morita, Akimichi
    Publication type:
    Article
    37
    38
    39

    English version of Japanese guidance for biologics in treating atopic dermatitis.

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2023, v. 50, n. 10, p. e311, doi. 10.1111/1346-8138.16932
    By:
    • Saeki, Hidehisa;
    • Akiyama, Masashi;
    • Abe, Masatoshi;
    • Igarashi, Atsuyuki;
    • Imafuku, Shinichi;
    • Ohya, Yukihiro;
    • Katoh, Norito;
    • Kameda, Hideto;
    • Kabashima, Kenji;
    • Tsunemi, Yuichiro;
    • Hide, Michihiro;
    • Ohtsuki, Mamitaro
    Publication type:
    Article
    40
    41

    English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis.

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2023, v. 50, n. 5, p. e138, doi. 10.1111/1346-8138.16797
    By:
    • Saeki, Hidehisa;
    • Mabuchi, Tomotaka;
    • Asahina, Akihiko;
    • Abe, Masatoshi;
    • Igarashi, Atsuyuki;
    • Imafuku, Shinichi;
    • Okubo, Yukari;
    • Komine, Mayumi;
    • Takahashi, Kenzo;
    • Torii, Hideshi;
    • Morita, Akimichi;
    • Yotsuyanagi, Hiroshi;
    • Watanabe, Akira;
    • Ohtsuki, Mamitaro
    Publication type:
    Article
    42
    43
    44
    45

    English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2023, v. 50, n. 2, p. e41, doi. 10.1111/1346-8138.16691
    By:
    • Saeki, Hidehisa;
    • Mabuchi, Tomotaka;
    • Asahina, Akihiko;
    • Abe, Masatoshi;
    • Igarashi, Atsuyuki;
    • Imafuku, Shinichi;
    • Okubo, Yukari;
    • Komine, Mayumi;
    • Sano, Shigetoshi;
    • Torii, Hideshi;
    • Morita, Akimichi;
    • Yotsuyanagi, Hiroshi;
    • Watanabe, Akira;
    • Ohtsuki, Mamitaro
    Publication type:
    Article
    46
    47
    48
    49
    50